| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Australia | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Canada | 2 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Measurement | |
| #2 | Biotechnology | |
| #3 | Pharmaceuticals | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Unspecified technologies | |
| #5 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mcintyre John A | 14 |
| Publication | Filing date | Title |
|---|---|---|
| AU2009289520A1 | Biomarkers, kits, and method for diagnosing, monitoring, and/or staging Alzheimer's disease | |
| US2009071842A1 | Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions | |
| US2006141541A1 | Method of detecting or diagnosing of a neurodegenerative disease or condition | |
| US7368542B2 | Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |